First patients to try new pill targeting Hard-to-Treat cancers
Disease control
Recruiting now
This is the first study in people to test a new oral medication called JMKX005425. It aims to find a safe dose and see if it helps control advanced solid tumors that have specific genetic markers (MSI-H or dMMR). The study will enroll about 102 patients to check for side effects …
Phase: PHASE1 • Sponsor: Jemincare • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC